Dr. Nicole Lopez -- Pharmaceutical Payment Report
This page provides a comprehensive transparency report for Dr. Nicole Lopez, a Oncology physician based in City, AL. All payment data is sourced from the CMS Open Payments (Sunshine Act) database. Dr. Nicole Lopez has received $35,299.80 in total pharmaceutical industry payments across 1 transactions from 1 pharmaceutical companies.
Physician Profile
The following profile information is sourced from the National Provider Identifier (NPI) registry and CMS Open Payments records.
- Full Name: Dr. Nicole Lopez
- Medical Specialty: Oncology
- Practice Location: City, AL, Alabama
- NPI Number: 1663386763
- Transparency Score: 50/100
- Payment Records Span: 2025-10-02 to 2025-10-02
Payment Summary
Dr. Nicole Lopez has received a total of $35,299.80 in pharmaceutical industry payments across 1 recorded transactions in the CMS Open Payments database. The average payment amount is $35,299.80 per transaction.
- Total Payments Received: $35,299.80
- Number of Transactions: 1
- Average Payment: $35,299.80
- Transparency Score: 50/100 -- This score reflects the overall payment profile relative to peers in Oncology. A higher score indicates fewer or more routine payments.
- Number of Pharma Relationships: 1 pharmaceutical companies
Payment Breakdown by Category
The following table shows how Dr. Nicole Lopez's pharmaceutical payments break down by payment category. Understanding the mix of payment types provides important context about the nature of the doctor-pharma relationship.
| Payment Category | Amount | Description |
|---|---|---|
| Speaking & Education | $35,299.80 | Promotional speaking, CME events, and educational presentations |
The largest payment category for Dr. Nicole Lopez is Speaking & Education, accounting for 100% ($35,299.80) of total pharmaceutical payments received. This suggests active involvement in pharmaceutical company advisory and educational programs.
Pharmaceutical Company Relationships
The following pharmaceutical and medical device companies have made payments to Dr. Nicole Lopez. Click on any company name to view their full physician payment profile and spending patterns.
| Company | Total Paid | Transactions |
|---|---|---|
| Pfizer Inc | $35,299.80 | 1 |
Dr. Nicole Lopez has a financial relationship with Pfizer Inc, receiving $35,299.80 in total. Having a single pharmaceutical company relationship means all payments come from one source, which may indicate a focused consulting or research relationship.
AI Transparency Analysis
The following analysis was generated by artificial intelligence based on Dr. Nicole Lopez's payment history, specialty peer comparisons, and payment pattern analysis. This analysis is not medical or legal advice.
Dr. Nicole Lopez, an Oncologist in City, AL, has a pharmaceutical payment profile characterized by a single, substantial payment. With a total of $35,299.80 from pharmaceutical companies, this amount is significantly higher than the typical payment volume observed among oncologists. While the average oncologist might receive payments spread across various activities and companies, Dr. Lopez's profile shows one payment from Pfizer Inc. for $35,299.80, designated for speaking engagement in October 2025. This singular, large speaking fee from a major pharmaceutical company, Pfizer Inc., warrants careful consideration. The payment type is exclusively for speaking, which can be a legitimate way for pharmaceutical companies to educate healthcare professionals about new treatments or research findings. However, the magnitude of this single payment, especially when it represents the entirety of reported payments, raises questions about potential influence. It is crucial for patients to understand that while such payments can facilitate the dissemination of important medical information, they also create a potential for bias. The financial relationship, even for educational purposes, could subtly influence a physician's perspective on a drug or treatment. Therefore, while this payment doesn't automatically indicate compromised care, it suggests a significant professional engagement with a pharmaceutical entity that patients should be aware of. Patients should view this information as a prompt for open communication with their physician about treatment options and the rationale behind them, ensuring that all decisions are made in their best interest, free from undue influence.
Patient Guidance: Questions to Ask Your Doctor
If Dr. Nicole Lopez is your physician, here is practical guidance on how to understand and discuss pharmaceutical industry relationships:
Understanding your doctor's financial relationships with pharmaceutical companies is an important aspect of informed healthcare. For Dr. Lopez, the data shows a single, substantial payment from Pfizer Inc. for speaking. While this can be a legitimate form of professional engagement, it's wise to be aware of it. When discussing treatment options, consider asking your doctor about the rationale behind their recommendations, especially if a specific drug is involved. You might ask, "Are there alternative treatments available, and what are their pros and cons?" or "Could you explain why this particular medication is the best choice for my situation?" Red flags might include a doctor who seems overly enthusiastic about a particular drug without a clear clinical justification, or who consistently prescribes a brand-name medication when a generic alternative is available and equally effective. It's important to remember that most doctors are ethical and prioritize patient well-being. Pharma relationships are common and can be beneficial for staying updated on medical advancements. However, transparency allows you to have a more complete picture and engage in more informed conversations about your care. If you have persistent concerns, discussing them openly with your doctor is the first step.
Peer Comparison: How Dr. Nicole Lopez Compares to Other Oncology Physicians
Oncologists typically receive payments from pharmaceutical companies for various activities such as research, consulting, and speaking. While payment amounts can vary widely, the average total payment volume for oncologists often falls within a range of a few thousand dollars annually, sometimes exceeding $10,000 for those heavily involved in research or speaking. Dr. Lopez's reported total of $35,299.80 from a single payment is considerably higher than the average, particularly as it represents a sole transaction. This places her significantly above the typical payment profile for her specialty.
Recent Payment Records
The following table shows the most recent pharmaceutical industry payments recorded for Dr. Nicole Lopez in the CMS Open Payments database. Click on any payment to view the full report.
| Company | Amount | Type | Drug/Device | Date | Conflict Level |
|---|---|---|---|---|---|
| Pfizer Inc | $35,299.80 | speaking | N/A | 2025-10-02 | Not Assessed |
Frequently Asked Questions About Dr. Nicole Lopez's Pharma Payments
Below are common questions patients ask about physician pharmaceutical payment data.
Is Dr. Nicole Lopez taking too much pharma money?
Dr. Lopez has received a single payment of $35,299.80 from Pfizer Inc. for speaking. While this amount is higher than the average total payments received by many oncologists, it represents one specific engagement. The key factor is that this single payment constitutes her entire reported pharmaceutical income. While this payment is substantial, it's important to consider the context: it's for speaking, a common professional activity. Whether this is 'too much' is subjective, but it certainly represents a significant financial relationship with one company that patients should be aware of and discuss with their doctor.
What pharma companies pay Dr. Nicole Lopez?
Dr. Nicole Lopez receives payments exclusively from Pfizer Inc. The total amount reported is $35,299.80, which is attributed to a single speaking engagement scheduled for October 2, 2025.
Should I switch doctors because of pharma payments?
Switching doctors solely based on pharmaceutical payments is generally not recommended unless you have specific, evidence-based concerns about your care. Most doctors engage in professional relationships with pharmaceutical companies to stay informed. Dr. Lopez's payment is for speaking, which is a common practice. If you have concerns, the best approach is to discuss them openly with Dr. Lopez. Ask about treatment options, the rationale behind their recommendations, and any potential conflicts of interest. If, after this discussion, you still feel uncomfortable or that your concerns are not being adequately addressed, then exploring other options might be considered.
What kinds of payments does this doctor receive?
Dr. Nicole Lopez receives payments exclusively for speaking engagements. The total amount reported is $35,299.80, which is a single payment from Pfizer Inc. for a speaking engagement scheduled in the future. There are no reported payments for consulting, meals, travel, research, or ownership interests.
How do these payments compare to other Oncology?
Dr. Lopez's total reported payment of $35,299.80 from a single speaking engagement is significantly higher than the average total payment volume for oncologists. While oncologists may receive payments for various activities, the average annual total is often in the low thousands, with some exceeding $10,000. Her profile, dominated by one large payment, stands out compared to the more distributed payment patterns often seen in her specialty.
Do pharma payments affect prescribing quality?
Research on the influence of pharmaceutical payments on physician prescribing behavior is complex and ongoing. Some studies suggest that even small payments, such as meals, can influence prescribing habits. Larger payments, like those for speaking or consulting, may have a more pronounced effect. However, it's not a universal rule, and many physicians maintain their prescribing independence. The key is transparency and critical evaluation. Patients should view these payments as one piece of information and focus on their doctor's overall clinical judgment, evidence-based medicine, and open communication about treatment choices.
How can I verify this payment data?
You can verify this payment data directly through the Centers for Medicare & Medicaid Services (CMS) Open Payments database. This is a public resource that lists payments made by pharmaceutical and medical device companies to physicians and teaching hospitals. You can search for Dr. Nicole Lopez by her name or National Provider Identifier (NPI) number, which is 1663386763. The database provides detailed information about the paying company, the physician, the amount, and the nature of the payment.
Understanding This Doctor Payment Report
This transparency report for Dr. Nicole Lopez is based on data from the CMS Open Payments database, which is maintained by the Centers for Medicare and Medicaid Services under the Physician Payments Sunshine Act. Here are important things to understand:
- Payment does not imply wrongdoing. Many pharmaceutical payments represent legitimate professional activities such as consulting on drug development, speaking at medical education events, and conducting clinical research.
- Context matters. A large payment for conducting a clinical trial has very different implications than a large payment for promotional speaking. The payment breakdown by category above provides this context.
- Peer comparison is important. Whether a payment amount is unusual depends heavily on the physician's specialty, geographic location, and career stage. Oncology physicians may have very different payment norms than physicians in other fields.
- Data may be incomplete. The CMS Open Payments database captures payments from pharmaceutical and medical device manufacturers. It does not include payments from other sources, such as hospitals, insurance companies, or government agencies.
- Reporting thresholds apply. Small payments below certain thresholds may not be individually reported. The totals reflect payments above reporting minimums set by CMS regulations.
About the Physician Payments Sunshine Act
The Physician Payments Sunshine Act, enacted as Section 6002 of the Affordable Care Act in 2010, requires pharmaceutical and medical device companies to report payments and other transfers of value to physicians and teaching hospitals to CMS. This law was designed to increase transparency in the financial relationships between the healthcare industry and medical providers.
Under this law, Dr. Nicole Lopez's pharmaceutical payments are publicly disclosed. The types of reportable transactions include consulting fees, compensated speaking or educational activities, honoraria, gifts, entertainment, food and beverages, travel and lodging, education or conference attendance, research grants, charitable contributions, royalties or licenses, current or prospective ownership interests, and direct compensation for services other than consulting.
The Open Payments data for Dr. Nicole Lopez and all other physicians can be accessed at the official CMS Open Payments website.
Related Resources
- Oncology Specialty Payment Data -- See payment patterns for all oncology physicians
- Alabama Physician Payments -- Browse pharmaceutical payments to physicians in Alabama
- Oncology Physicians in Alabama -- Compare Dr. Nicole Lopez to peers in the same state and specialty
- Pfizer Inc Payment Profile -- View all payments made by Dr. Nicole Lopez's largest pharmaceutical partner
- Search for Another Doctor or Company -- Look up any physician or pharmaceutical company in our database
- Official CMS Open Payments Database -- Verify payment data directly with the federal government
- NPI Registry -- Look up Dr. Nicole Lopez's NPI (1663386763) in the official provider registry
Data from CMS Open Payments (Sunshine Act). Payment does not imply wrongdoing. AI analysis is not medical or legal advice. Consult your healthcare provider about any concerns.